Chesapeake Asset Management’s AbbVie ABBV Stock Holding History

Chesapeake Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5	Closed	-$71	–	337
2024 Q1	$71	Buy	+5	New	+$862	﹤0.01%	321
2023 Q4	–	Sell	-5	Closed	-$477	–	380
2023 Q3	$477	Hold	5	–	–	﹤0.01%	405
2023 Q2	$1.35K	Buy	+5	New	+$733	﹤0.01%	369

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chesapeake Asset Management's ABBV Position: Q1 2026 in Review

Chesapeake Asset Management reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $202K and leaving 5,656 shares worth $1.23M. The position accounts for 0.98% of the portfolio, ranked #22.

Chesapeake Asset Management first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.02M in Q3 2023. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Chesapeake Asset Management held 5,656 shares of AbbVie worth $1.23M as of Q1 2026.
Chesapeake Asset Management sold 911 AbbVie shares in Q1 2026, an estimated $202K.
AbbVie made up 0.98% of Chesapeake Asset Management's portfolio in Q1 2026, its #22 holding.
Chesapeake Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Chesapeake Asset Management's AbbVie position peaked at $2.02M in Q3 2023.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.